Chondroitin nanocapsules enhanced doxorubicin induced apoptosis against leishmaniasis via Th1 immune response

International Journal of Biological Macromolecules

Volumn 79, Issue , 2015, Pages 27-36

  Chaurasia, Mohini ^a   Pawar, Vivek K ^b   Jaiswal, Anil K ^b   Dube, Anuradha ^b   Paliwal, Sarvesh k ^c   Chourasia, Manish K ^b  

^a AMITY UNIVERSITY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c BANASTHALI UNIVERSITY   (India)

Author keywords

Apoptosis; Cell cycle arrest; Chondroitin sulphate; Cytokine; Doxorubicin

Indexed keywords

CHONDROITIN 6 SULFATE; DOXORUBICIN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; NANOCAPSULE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ANTIPROTOZOAL AGENT; CHONDROITIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTILEISHMANIAL ACTIVITY; APOPTOSIS; ARTICLE; CC50; CELL VIABILITY; CELLULAR IMMUNITY; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DOWN REGULATION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG UPTAKE; ENZYME ACTIVITY; EXCIPIENT COMPATIBILITY; G1 PHASE CELL CYCLE CHECKPOINT; GROWTH INHIBITION; IC50; IC90; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LEISHMANIA DONOVANI; LEISHMANIASIS; MOUSE; NANOFABRICATION; NONHUMAN; PARASITE LOAD; PROMASTIGOTE; PROTEIN EXPRESSION; SYRIAN HAMSTER; TH1 CELL; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CRICETULUS; DRUG EFFECTS; DRUG FORMULATION; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LEISHMANIASIS, VISCERAL; MONOCYTE; PARASITOLOGY; TH1 TH2 BALANCE; TH2 CELL;

CRICETINAE;

ANIMALS; ANTIPROTOZOAL AGENTS; APOPTOSIS; CELL LINE; CHONDROITIN; CRICETULUS; DOXORUBICIN; DRUG COMPOUNDING; DRUG LIBERATION; G1 PHASE CELL CYCLE CHECKPOINTS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MICE; MONOCYTES; NANOCAPSULES; TH1 CELLS; TH1-TH2 BALANCE; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929463379     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2015.04.043     Document Type: Article

References (38)

1. Berman J.D. Clin. Infect. Dis. 1997, 24:684-703.
2. Peacock C.S., Seeger K., Harris D., Murphy L., Ruiz J.C., Quail M.A., Peters N., Adlem E., Tivey A., Aslett M., Kerhornou A., Ivens A., Fraser A., Rajandream M.-A., Carver T., Norbertczak H., Chillingworth T., Hance Z., Jagels K., Moule S., Ormond D., Rutter S., Squares R., Whitehead S., Rabbinowitsch E., Arrowsmith C., White B., Thurston S., Bringaud F., Baldauf S.L., Faulconbridge A., Jeffares D., Depledge D.P., Oyola S.O., Hilley J.D., Brito L.O., Tosi L.R.O., Barrell B., Cruz A.K., Mottram J.C., Smith D.F., Berriman M. Nat. Genet. 2007, 39:839-847.
3. Choi C.M., Lerner E.A. J. Investig. Dermatol. Symp. Proc. 2001, 6:175-182.
4. Kaye P., Scott P. Nat. Rev. Microbiol. 2011, 9:604-615.
5. Stanley A.C., Engwerda C.R. Immunol. Cell Biol. 2006, 85:138-147.
6. Mukhopadhyay A., Basu S.K. Proc. Indian Natl. Sci. Acad. Part B 2002, 68:361-370.
7. Kunjachan S., Jose S., Thomas C.A., Joseph E., Kiessling F., Lammers T. Fundam. Clin. Pharmacol. 2012, 26:63-71.
8. Jain N.K., Mishra V., Mehra N.K. Expert Opin. Drug Deliv. 2013, 10:353-367.
9. Sakai S., Akiyama H., Harikai N., Toyoda H., Toida T., Maitani T., Imanari T. Immunol. Lett. 2002, 84:211-216.
10. Garnier P., Gibbs R.V., Rider C.C. Immunol. Lett. 2003, 85:53-58.
11. Iovu M., Dumais G., du Souich P. Osteoarthritis Cartilage 2008, 16(Supplement 3):S14-S18.
12. Sundar S. Trop. Med. Int. Health 2001, 6:849-854.
13. Chappuis F., Sundar S., Hailu A., Ghalib H., Rijal S., Peeling R.W., Alvar J., Boelaert M. Nat. Rev. Microbiol. 2007, 5:873-882.
14. Chatterjee K., Zhang J., Honbo N., Karliner J.S. Cardiology 2010, 115:155-162.
15. Sett R., Basu N., Ghosh A.K., Das P.K. J. Parasitol. 1992, 78:350-354.
16. Singh G., Dey C.S. Acta Trop. 2007, 103:172-185.
17. Park J., Fong P.M., Lu J., Russell K.S., Booth C.J., Saltzman W.M., Fahmy T.M. Nanomed.: Nanotechnol. Biol. Med. 2009, 5:410-418.
18. Mukherjee S., Das L., Kole L., Karmakar S., Datta N., Das P.K. J. Infect. Dis. 2004, 189:1024-1034.
19. Asthana S., Jaiswal A.K., Gupta P.K., Pawar V.K., Dube A., Chourasia M.K. Antimicrob. Agents Chemother. 2013, 57:1714-1722.
20. Asthana S., Jaiswal A.K., Gupta P.K., Dube A., Chourasia M.K. Eur. J. Pharmaceut. Biopharmaceut. 2015, 89:62-73.
21. Jain V., Gupta A., Pawar V., Asthana S., Jaiswal A., Dube A., Chourasia M. Appl. Biochem. Biotechnol. 2014, 174:1309-1330.
22. Asthana S., Gupta P.K., Chaurasia M., Dube A., Chourasia M.K. Expert Opin. Drug Deliv. 2013, 10:1633-1651.
23. Kunjachan S., Gupta S., Dwivedi A.K., Dube A., Chourasia M.K. J. Microencapsul. 2011, 28:301-310.
24. Mora-Huertas C.E., Fessi H., Elaissari A. Int. J. Pharmaceut. 2010, 385:113-142.
25. Zhao M., Liu Y., Hsieh R.S., Wang N., Tai W., Joo K.-I., Wang P., Gu Z., Tang Y. J. Am. Chem. Soc. 2014, 136:15319-15325.
26. Rollett A., Reiter T., Nogueira P., Cardinale M., Loureiro A., Gomes A., Cavaco-Paulo A., Moreira A., Carmo A.M., Guebitz G.M. Int. J. Pharmaceut. 2012, 427:460-466.
27. Eksborg S. J. Pharm. Sci. 1978, 67:782-785.
28. Wang Y., Xiao Y., Zhou H., Chen W., Tang R. RSC Adv. 2013, 3:23133-23138.
29. Leteux C., Chai W., Loveless R.W., Yuen C.-T., Uhlin-Hansen L., Combarnous Y., Jankovic M., Maric S.C., Misulovin Z., Nussenzweig M.C., Feizi T. J. Exp. Med. 2000, 191:1117-1126.
30. East L., Isacke C.M. Biochim. Biophys. Acta (BBA) - Gen. Subj. 2002, 1572:364-386.
31. Kolset S.O., Gallagher J.T. Biochim. Biophys. Acta 1990, 1032:191-211.
32. Kima P.E., Soong L. Front. Immunol. 2013, 4:156.
33. Ghalib H.W., Piuvezam M.R., Skeiky Y.A., Siddig M., Hashim F.A., el-Hassan A.M., Russo D.M., Reed S.G. J. Clin. Investig. 1993, 92:324-329.
34. Carvalho E.M., Bacellar O., Brownell C., Regis T., Coffman R.L., Reed S.G. J. Immunol. 1994, 152:5949-5956.
35. Uyemura K., Pirmez C., Sieling P.A., Kiene K., Paes-Oliveira M., Modlin R.L. J. Immunol. 1993, 151:7095-7104.
36. Murray H.W., Tsai C.W., Liu J., Ma X. Infect. Immun. 2006, 74:4370-4374.
37. Kemp K., Kemp M., Kharazmi A., Ismail A., Kurtzhals J.A.L., Hviid L., Theander T.G. Clin. Exp. Immunol. 1999, 116:500-504.
38. Li J., Hunter C.A., Farrell J.P. J. Immunol. 1999, 162:974-979.